title: A fair innings for NICE?
authors.affiliation: Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, United Kingdom. N.Freemantle@bham.ac.uk
authors.forename: Nick
authors.initials: N
authors.lastname: Freemantle
authors.forename: Karen
authors.initials: K
authors.lastname: Bloor
authors.forename: Joanne
authors.initials: J
authors.lastname: Eastaugh
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000191:economics*; D016001:Confidence Intervals; D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D018691:Excitatory Amino Acid Antagonists / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D019057:Quality-Adjusted Life Years; D019782:Riluzole / Q000191:economics / Q000627:therapeutic use; D018709:Statistics, Nonparametric; D006113:United Kingdom
chemical_list: D018691:Excitatory Amino Acid Antagonists; D019782:Riluzole